Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2005-09-06
2005-09-06
Chen, Shin-Lin (Department: 1632)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S134100, C424S139100
Reexamination Certificate
active
06939544
ABSTRACT:
Disclosed are isolated antibodies that specifically bind a murine pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptide. The inventive antibodies are useful in assays to determine levels of PTTG proteins or PTTG-C peptides present in a given sample (e.g., tissue samples, biological fluids, Western blots). The antibodies can also be used to purify PTTG proteins or PTTG-C peptides from crude cell extracts and the like. The antibodies are also considered therapeutically useful to counteract and/or supplement the biological effect of PTTG proteins in vivo.
REFERENCES:
patent: WO 90/09442 (1990-08-01), None
patent: WO 93/25712 (1993-12-01), None
patent: WO 98/22587 (1998-05-01), None
Wang et al., Feb. 2000, Endocrinology, vol. 141, No. 2, p. 763-771.
Wang et al., Mar. 2000, Journal of Biological Chemistry, vol. 275, No. 11, p. 7459-7461.
PCT International Search Report—PCT/US 97/21463, Nov. 22, 1997.
Marra, M., et al., “The WashU-HHMI Mouse EST project, AC W81747”, EMBL Database, Jun. 27, 1996, Heidelberg, XP002066845.
Hillier, L., et al., The WashU-Merck EST project, AC AA007646, EMBL Database, Jul. 28, 1996, Heidelberg, XP002066846.
Holton, T., et al., “ACQ57612”, EMBL Database, Sep. 5, 1994, Heidelberg, XP002066847.
Nippon Telegraph and Telephone Corp.: “ACQ75553”, EMBL Database, Aug. 4, 1995, Heidelberg, XP002066848.
Goosky, R., et al., “Transforming DNA Sequences Present in Human Prolactin-Secreting Pituitary Tumors”, Molec. Endocrin., 5(11): 1687-1695, Nov. 1991.
Pei, L., et al., “Isolation and Characterization of a Pituitary Tumor-Transforming Gene (PTTG)”, Molec. Endocrin., 11(4): 433-441, Apr. 1997.
Shimon, L., et al., “Genetic Basis of Endocrine Disease”, J. Clin. Endocrin. And Metab., 82(6): 1675-1681, Jun. 1997.
Chen, L., et al., “Identification of the human pituitary tumor transforming gene (hPTTG) family: molecular structure, expression, and chromosomal localization.”, 1: Gene 2000, May 2; 248(102): 41-50, Abstract Only.
Heaney, A.P., “Expression of pituitary-tumor transforming gene in colorectal tumours”, 1: Lancet 2000 Feb. 26; 355(9205): 716-9.
Heaney, A.P., “Early Involvement of Estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis”, 1: Nat Med Nov. 1999, 5(11): 1317-21.
Suhardja, A.S., et al., “Molecular pathogenesis of pituitary adenomas: a review,”, Acta Neurochir (Wien) 1999; 141(7): 729-36, Abstract Only.
Ren, R., et al., “Identification of a ten-amino acid proline-rich SH3 binding site”, Science Feb 19, 1993; 259(5098): 1157-61. Abstract Only.
Liu, X., et al., “The v-Sre SH3 domain binds phosphatidylinositol 3′-kinase”, Mol Cell Biol Sep. 1993; 13(9): 5225-32. Abstract Only.
Gout, L., et al., “The GTPase dynamin binds to and is activated by a subset of SH3 domains.” Cel Oct. 8, 1993; 75(1): 25-36.
Yu, H., et al., “Solution structure of the SH3 domain of Sre and identification of its Ugan-binding site.” Science Dec. 4, 1992; 258(5088): 1665-8, Abstract Only.
Lee, I.A., et al., “Cloning and expression of human cDNA encoding human homologue of pituitary tumor transforming gene”, Biochem Mol. Biol Int May 1999; 47(5): 891-7, Abstract Only.
Zou, H., et al., “Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis”, Science Jul. 16, 1999; 285(5426): 418-22. Abstract Only.
Zhang, X., et al., “Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas” J Clin Endocrinol Metab Feb. 1999; 84(2): 761-7.
Prezant, T.R., et al., “An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors; evidence for hPTTG family.”, J Clin Endocrinol Metab Mar. 1999; 84(3): 1149-52.
Fujimoto, N., et al., “Establishment of an estrogen responsive rat pituitary cell sub-line MtTE-2.” Endocr J Jun. 1999: 46(3): 389-96. Abstract Only.
Ramos-Morales, F., et al., “Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product”, Oncogene Jan. 20, 2000; 19(3): 403-9. Abstract Only.
McCabe C.J., et al., “PTTG-a new pituitary tumour transforming gene”, J Endocrinol Aug. 1999; 162(2): 163-6. Abstract Only.
Kakar, S.S., “Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG).”, Gene Nov. 29, 1999; 240(2): 317-24. Abstract Only.
Dominguez A., et al., “hpttg, a human homologue of rat pttg, is overexpressed in hematopolectic neoplasma. Evidence for a transcriptional activation function of hPTTG.”, Oncogene Oct. 29, 1998; 17(17): 2187-93, Abstract Only.
Pei, L., “Pituitary tumor-transforming gene protein associates with ribosomal protein S10 and a novel human homologue of DnsJ in testicular cells”, J Biol Chem Jan. 29, 1999; 274(5): 3151-8.
Saez, C., et al., “hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplaias.”, Oncogene Sep. 23, 1999; 18(39): 5473-6. Abstract Only.
Pei, L., “Genomic Organization and Identification of an enhancer element containing binding sites for multiple proteins in rat pituitary tumor-transforming gene”, J Biol Chem Feb. 27, 1998; 273(9): 5219-25.
Wang, Z., et al., “Characterization of the murine pituitary tumor transforming gene (PTTG)and its promoter.”, Endocrinology Feb. 2000; 141(2): 763-71.
Zhang, X., et al., “Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).”, Mol Endocrinol Jan. 1999; 13(1): 156-66.
Heaney, Anthony, P., et al., “Pituitary tumor transforming gene: a novel factor in pituitary tumour formation” Balliere's Clinical Endocrinology and Metabolism, vol. 13, No. 3, pp. 367-380, 1999.
Dominguez, Africa et al.,hpttg, a human homologue of rat pttg, is overexpressed in hematopoiectic neoplasmas. Evidence for a transcriptional activation function of Hpttg, Oncogene, vol. 17, pp. 2187-2195 (1998).
XP-002193233, Chen, Leilei et al.,Identification of the human pituitary tumor transforming gene(hPTTG)family: molecular structure, expression, and chromosomal localization, Gene, vol. 248, pp. 41-50 (2000).
XP-002186232, Wang, Zhiyong et al.,Pituitary Tumor Transforming Gene(PTTG)Transforming and Transactivation Activity, The Journal of Biological Chemistry, vol. 275, No. 11, pp. 7459-7461 (Mar. 17, 2000).
Ohgi et al.;Expression of Rnase Rh from Rhizopus niveus in Yeast and Characterization of the Secreted Proteins, J. Biochem,vol. 1, pp. 775-785 (1991).
Kaye et al.,A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding, Proc. Natl. Acad. Sci., , vol. 87, pp. 6922-6926 (1990).
Rudinger;Characteristics of the amino acids as components of a peptide hormone sequence, Peptide Hormones, pp. 1-7 (1976).
Crystal;Transfer of Genes to Humans: Early Lessons and Obstacles to Success, Science, vol. 270, pp. 404-410 (1995).
Deonarain;Ligand-targeted receptor-mediated vectors for gene delivery, Exp. Opin. Ther. Patents, 8(1):53-69 (1998).
Eck et al.,Gene-Based Therapy, The Pharmacological Basis of Therapeutics, pp. 77-101 (1996).
Accession No. AAT21011 (1996).
Accession No. H66067 (1995).
Horwitz Gregory A.
Melmed Shlomo
Zhang Xun
Cedars-Sinai Medical Center
Chen Shin-Lin
David Wright Tremaine LLP
Levy Seth D.
LandOfFree
Antibodies against mouse pituitary tumor transforming gene... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies against mouse pituitary tumor transforming gene..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies against mouse pituitary tumor transforming gene... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419303